Literature DB >> 28153341

Patients and caregivers costs for colonoscopy-based colorectal cancer screening: Experience of low-income individuals undergoing free colonoscopies.

Sonja Hoover1, Sujha Subramanian2, Florence K L Tangka3, Maggie Cole-Beebe1, Amy Sun4, Cheryl L Kramer5, Gina Pacillio5.   

Abstract

Many studies have documented barriers to colorectal cancer screenings. However, there is lack of comprehensive information on the time and costs borne by low-income patients and the persons accompanying the patient (caregiver) for colonoscopies in the United States. We surveyed patients in three health clinics in Philadelphia retrospectively who had undergone free colonoscopies in the previous 18-month period. Participants were asked questions about time and out-of-pockets expenses for themselves and their caregivers. Even when colonoscopies were free to the patient through Colorectal Cancer Control Program funded by the Centers for Disease Control and Prevention, the patient and caregivers still incurred costs in relation to preparing for, undergoing, and recovering from a colonoscopy. These costs can be substantial and may account for some of the low colorectal cancer screening rates especially among the low-income populations. Patients' and caregivers' costs need to be considered when designing and implementing colorectal cancer control programs.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer screening; Colonoscopy; Patients and caregivers costs and cost analysis

Mesh:

Year:  2017        PMID: 28153341      PMCID: PMC5847315          DOI: 10.1016/j.evalprogplan.2017.01.002

Source DB:  PubMed          Journal:  Eval Program Plann        ISSN: 0149-7189


  18 in total

Review 1.  Adherence with colorectal cancer screening guidelines: a review.

Authors:  Sujha Subramanian; Michelle Klosterman; Mayur M Amonkar; Timothy L Hunt
Journal:  Prev Med       Date:  2004-05       Impact factor: 4.018

2.  Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults.

Authors:  Carrie N Klabunde; Sally W Vernon; Marion R Nadel; Nancy Breen; Laura C Seeff; Martin L Brown
Journal:  Med Care       Date:  2005-09       Impact factor: 2.983

3.  Modeling the cost-effectiveness of colorectal cancer screening: policy guidance based on patient preferences and compliance.

Authors:  Sujha Subramanian; Georgiy Bobashev; Robert J Morris
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

Review 4.  Economic studies in colorectal cancer: challenges in measuring and comparing costs.

Authors:  K Robin Yabroff; Laurel Borowski; Joseph Lipscomb
Journal:  J Natl Cancer Inst Monogr       Date:  2013

5.  Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.

Authors:  Steven J Heitman; Flora Au; Braden J Manns; S Elizabeth McGregor; Robert J Hilsden
Journal:  Clin Gastroenterol Hepatol       Date:  2008-06-05       Impact factor: 11.382

6.  Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.

Authors:  Ann G Zauber; Iris Lansdorp-Vogelaar; Amy B Knudsen; Janneke Wilschut; Marjolein van Ballegooijen; Karen M Kuntz
Journal:  Ann Intern Med       Date:  2008-10-06       Impact factor: 25.391

7.  Patient time requirements for screening colonoscopy.

Authors:  Daniel E Jonas; Louise B Russell; Robert S Sandler; Jon Chou; Michael Pignone
Journal:  Am J Gastroenterol       Date:  2007-06-29       Impact factor: 10.864

8.  The lack of paid sick leave as a barrier to cancer screening and medical care-seeking: results from the National Health Interview Survey.

Authors:  Lucy A Peipins; Ashwini Soman; Zahava Berkowitz; Mary C White
Journal:  BMC Public Health       Date:  2012-07-12       Impact factor: 3.295

9.  Using a discrete choice experiment to inform the design of programs to promote colon cancer screening for vulnerable populations in North Carolina.

Authors:  Michael P Pignone; Trisha M Crutchfield; Paul M Brown; Sarah T Hawley; Jane L Laping; Carmen L Lewis; Kristen Hassmiller Lich; Lisa C Richardson; Florence Kl Tangka; Stephanie B Wheeler
Journal:  BMC Health Serv Res       Date:  2014-11-30       Impact factor: 2.655

10.  Cancer screening test use - United States, 2013.

Authors:  Susan A Sabatino; Mary C White; Trevor D Thompson; Carrie N Klabunde
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-08       Impact factor: 17.586

View more
  2 in total

1.  Importance of implementation economics for program planning-evaluation of CDC's colorectal cancer control program.

Authors:  Florence K L Tangka; Sujha Subramanian
Journal:  Eval Program Plann       Date:  2016-11-24

Review 2.  Efficacy and safety of celecoxib on the incidence of recurrent colorectal adenomas: a systematic review and meta-analysis.

Authors:  Sajesh K Veettil; Surakit Nathisuwan; Siew Mooi Ching; Peerawat Jinatongthai; Kean Ghee Lim; Siang Tong Kew; Nathorn Chaiyakunapruk
Journal:  Cancer Manag Res       Date:  2019-01-09       Impact factor: 3.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.